公司資料
PaxMedica 股價、新聞與催化劑
- 股票代碼:
- PXMD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (+14.29%)
收盤價
最後更新: 2026年8月20日
—
市值
股價為何變動
Current closing-price context is not available for PXMD.
公司概覽
業務概覽
PaxMedica is a biotechnology company focused on neurodevelopmental disorders and other high-unmet-need conditions. Its story is centered on using a small pipeline to address difficult patient populations.
所在地與產業分類
PaxMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商業模式特徵
The company depends on clinical progress, capital efficiency, and the ability to keep a narrow pipeline moving. Investors usually watch early data and whether the company can sharpen its thesis.
生技產業定位
PaxMedica occupies a speculative small-cap biotech niche. It is catalyst-sensitive because the company is still proving its therapeutic relevance.
未來催化劑
- PaxMedica’s catalysts are PAX-101 and the neurodevelopment / rare-disease programs, where any update can materially change sentiment. The stock remains highly data-dependent.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。